Local Effects of Epinephrine on Lactate, Glucose, Lipid and Protein Metabolism in Bilaterally Perfused Human Legs

NCT01116609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2011-11-07

No results posted yet for this study

Summary

The purpose of this study is to define the local metabolic effects of epinephrine in the bilaterally perfused human leg.

Conditions

  • Healthy

Interventions

DRUG

Epinephrine

unilateral leg infusion of Epinephrine 0.4 micrograms/m2/min

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Niels Moller, Professor · Medical Research Laboratories, Aarhus University, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2009-11-30
Completion
2010-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01116609 on ClinicalTrials.gov